The Jackson Laboratory is fast-tracking the breeding and distribution of a unique transgenic mouse model for worldwide coronavirus research.
The Jackson Laboratory (JAX) has received $2.5 million from The Mark Foundation for Cancer Research to study in mice the influence of host genetics on response to immunotherapy. The goal of this project is to generate insights that will empower future decisions about the best treatments for cancer patients based on their genetic backgrounds.
New research shows that the presence of Odoribacter in the gut alters sleep patterns differently in mice depending on their genetic background.
The repeated clinical trial failures of Alzheimer’s disease therapies based on clearing beta-amyloid have been discouraging, but new research strategies and capabilities are providing renewed hope.
The National Cancer Institute has awarded Jackson Laboratory cancer researcher Gary Ren a five-year grant totaling $1,946,663 to study how chemotherapy-induced changes in the lung stroma foster the growth of metastatic breast tumor cells in the lung.
Jackson Laboratory (JAX) Associate Professor Shuzhao Li uses high-resolution mass spectrometers to quantify metabolism, measuring thousands of small molecules in the body.
The Jackson Laboratory, The Children’s Cancer Therapy Development Institute, and Champions Oncology offer rapid, cost-effective services to the pharma, biopharma and biotech industry, speeding the right drug to the right pediatric cancer whenever possible.
JAX neuroscientist Erik Bloss develops high-resolution tools to study the wiring of neuronal circuits in normal brains and Alzheimer’s disease.